Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bright Minds Biosciences Inc. - common stock
(NQ:
DRUG
)
46.62
-1.90 (-3.92%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
302,792
Open
48.75
Bid (Size)
46.55 (1)
Ask (Size)
47.50 (5)
Prev. Close
48.52
Today's Range
44.25 - 50.74
52wk Range
0.9300 - 79.02
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement
November 04, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
November 04, 2024
A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biotech stocks joined the top 10.
Via
Benzinga
Topics
Government
Exposures
Political
Performance
YTD
+2435.62%
+2435.62%
1 Month
+4257.01%
+4257.01%
3 Month
+4138.18%
+4138.18%
6 Month
+4138.18%
+4138.18%
1 Year
+3752.89%
+3752.89%
More News
Read More
What's Going On With Bright Minds Biosciences Stock?
October 21, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
October 21, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
MarketBeat Week in Review – 10/14 - 10/18
October 19, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
Crude Oil Down Over 1%; American Express Shares Fall After Q3 Results
October 18, 2024
Via
Benzinga
Exposures
Fossil Fuels
What's Going On With Bright Minds Biosciences Stock Friday?
October 18, 2024
Via
Benzinga
Dow Falls Over 100 Points; Netflix Posts Upbeat Results
October 18, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysis
October 17, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Bright Minds Biosciences (NASDAQ: DRUG) Soars 1800% Amid Short Squeeze Alongside PRSO, ILLR and NIVF
October 16, 2024
Via
AB Newswire
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views
October 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models
October 16, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
October 16, 2024
Via
Benzinga
Bright Minds Biosciences Stock Surges Almost 1,500%
October 16, 2024
Via
MarketBeat
Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
October 15, 2024
Via
Benzinga
Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events
October 03, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th
September 19, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
Bright Minds Biosciences Reports Improved Financial Position For Q3 Amid Ongoing R&D Efforts
August 16, 2024
Via
Benzinga
DRUG Stock Earnings: Bright Minds Biosciences Reported Results for Q3 2024
August 15, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
August 12, 2024
Via
InvestorPlace
DRUG Stock Earnings: Bright Minds Biosciences Reported Results for Q2 2024
May 20, 2024
Via
InvestorPlace
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
Via
Benzinga
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
March 29, 2024
Via
Benzinga
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
March 20, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.